hodgkin's lymphoma

Showing 51 - 75 of 96

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia Trial in Hershey (Clofar, Cyclophos, Alemtuzumab, Clofar,

Terminated
  • Leukemia
  • +5 more
  • Clofar, Cyclophos, Alemtuzumab
  • Clofar, Cyclophos,Alemtuzumab(Ph II)
  • Hershey, Pennsylvania
    Penn State College of Medicine, Penn State Milton S. Hershey Med
Mar 23, 2018

Hodgkin's Lymphoma Trial in Italy (ABVD, ABVD and Radiotherapy)

Completed
  • Hodgkin's Lymphoma
  • ABVD
  • ABVD and Radiotherapy
  • Aviano, Italy
  • +26 more
Feb 7, 2018

Lymphoma, Hodgkin's Lymphoma, Non-hodgkin's Lymphoma Trial in Goodyear (Pembrolizumab, Etoposide, Ifosfamide)

Withdrawn
  • Lymphoma
  • +2 more
  • Goodyear, Arizona
    Cancer Treatment Center of America @ Western Regional Medical Ce
Jun 23, 2017

Hodgkin Disease, Hodgkin's Lymphoma, Lymphoma Trial in Stanford (Gemcitabine, Vinorelbine, Carmustine)

Completed
  • Hodgkin Disease
  • +2 more
  • Stanford, California
    Stanford University School of Medicine
May 15, 2017

Diffuse, Large B-Cell, Lymphoma, Lymphoma, Low-Grade, T-Cell Lymphoma Trial in Boston (Busulfan (conditioning for AUTO

Completed
  • Diffuse, Large B-Cell, Lymphoma
  • +6 more
  • Busulfan (conditioning for AUTO transplant)
  • +11 more
  • Boston, Massachusetts
  • +1 more
Jan 19, 2017

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Buffalo (LBH589)

Terminated
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 11, 2017

Low Dose Chest Computed Tomography (CT) Screening

Completed
  • Hodgkin's Lymphoma
  • Low Dose CT
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
Dec 28, 2016

Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (radiation, biological, drug)

Terminated
  • Hematologic Malignancy
  • +11 more
  • Total Body Irradiation (TBI)
  • +5 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 19, 2016

Hematologic Malignancies, Acute Leukemia, MDS (MDS) Other Than RA or RARS Subtypes Trial in Philadelphia (drug, radiation,

Terminated
  • Hematologic Malignancies
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Nov 28, 2016

Prospective Study of Lymphoproliferative Diseases

Withdrawn
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Lymphoma
    • Morgantown, West Virginia
    • +1 more
    Nov 4, 2016

    Hodgkin's Lymphoma, Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in Lexington (Nestle Impact Advanced Recovery)

    Terminated
    • Hodgkin's Lymphoma
    • +2 more
    • Nestle Impact Advanced Recovery
    • Lexington, Kentucky
      University of Kentucky, Markey Cancer Center
    Oct 17, 2016

    Consolidation PET-based and Donor-based After Salvage Therapy in

    Terminated
    • Hodgkin's Lymphoma
    • Patients with negative PET after salvage therapy
    • Patients with positive PET after salvage therapy
    • Rozzano, Milano, Italy
    • +38 more
    Aug 16, 2016

    AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)

    Completed
    • AML
    • +8 more
    • Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jul 14, 2016

    Hodgkin's Lymphoma Trial in Worldwide (Panobinostat, Placebo)

    Completed
    • Hodgkin's Lymphoma
    • Los Angeles, California
    • +34 more
    May 27, 2016

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Gliwice (G-CSF (filgrastim), Cytosine arabinoside with G-CSF (filgrastim))

    Unknown status
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • G-CSF (filgrastim)
    • Cytosine arabinoside with G-CSF (filgrastim)
    • Gliwice, Poland
      Maria Sklodowska-Curie Memorial Cancer Center and Institute of O
    Mar 24, 2016

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Beijing (CART30)

    Recruiting
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • CART30
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Jan 26, 2016

    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Stem Cell Mobilization Trial in Tel-Hashomer (Plerixafor)

    Completed
    • Non-Hodgkin's Lymphoma
    • +3 more
    • Tel-Hashomer, Israel
      Chaim Sheba Medical Center
    Dec 1, 2015

    Dual Point PET Scan in Early Stage Hodgkin Lymphoma Bulky

    Unknown status
    • Hodgkin's Lymphoma
      • Alessandria, AL, Italy
      • +5 more
      Oct 16, 2015

      Hodgkin's Lymphoma Trial in Canada, United States (MGCD0103)

      Terminated
      • Hodgkin's Lymphoma
      • Chicago, Illinois
      • +4 more
      Jun 5, 2015

      Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Toronto (Clioquinol)

      Terminated
      • Acute Myeloid Leukemia
      • +6 more
      • Toronto, Ontario, Canada
        Princess Margaret Hospital
      Jun 19, 2015

      Hodgkin's Lymphoma Trial in Chennai (Escalated BEACOPP)

      Completed
      • Hodgkin's Lymphoma
      • Escalated BEACOPP
      • Chennai, Tamil Nadu, India
        Department of Medical Oncology, Cancer Institute (WIA), Adyar
      Feb 2, 2015

      Hodgkin's Lymphoma Trial in Belgium, France (BEACOPPesc, BEACOPPesc - ABVD - PET2)

      Completed
      • Hodgkin's Lymphoma
      • Antwerpen, Belgium
      • +95 more
      May 20, 2014

      Hodgkin's Lymphoma, Low Grade Lymphoma, Lymphoma Trial (AMG 655, Vorinostat, Bortezomib)

      Completed
      • Hodgkin's Lymphoma
      • +5 more
      • AMG 655
      • +2 more
      • (no location specified)
      Mar 3, 2014

      Hodgkin's Lymphoma Trial in Rozzano (Bendamustine, Gemcitabine, Vinorelbine)

      Unknown status
      • Hodgkin's Lymphoma
      • Rozzano, MI, Italy
        Istituto Clinico Humanitas
      Jan 28, 2014